(RTTNews) - Celldex Therapeutics, Inc. (CLDX), a clinical-stage pharmaceutical company, on Wednesday priced its public offering of 10.345 million shares at $29 per share. The gross proceeds of the offering are expected to be $300 million.
7 views
Celldex Therapeutics Prices $300 Mln Public Offering Of Shares At $29/shr; Stock Down
(RTTNews) - Celldex Therapeutics, Inc. (CLDX), a clinical-stage pharmaceutical company, on Wednesday priced its public offering of 10.345 million shares at $29 per share. The gross proceeds of the offering are expected…
